229 related articles for article (PubMed ID: 36649137)
1. [The role of steroid hormones in the neurodegenerative diseases].
Sadowska A; Grzesiak M
Postepy Biochem; 2022 Dec; 68(4):387-398. PubMed ID: 36649137
[TBL] [Abstract][Full Text] [Related]
2. Molecular Targets Underlying the Neuroprotective Effects of Boswellic Acid: A Systematic Review.
Khaafi F; Javadi B
Mini Rev Med Chem; 2023; 23(19):1912-1925. PubMed ID: 36998129
[TBL] [Abstract][Full Text] [Related]
3. Sex and gender differences in Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis: A narrative review.
Nicoletti A; Baschi R; Cicero CE; Iacono S; Re VL; Luca A; Schirò G; Monastero R;
Mech Ageing Dev; 2023 Jun; 212():111821. PubMed ID: 37127082
[TBL] [Abstract][Full Text] [Related]
4. Cerium oxide nanoparticles: a 'radical' approach to neurodegenerative disease treatment.
Naz S; Beach J; Heckert B; Tummala T; Pashchenko O; Banerjee T; Santra S
Nanomedicine (Lond); 2017 Mar; 12(5):545-553. PubMed ID: 28181459
[TBL] [Abstract][Full Text] [Related]
5. The Role of Sex and Sex Hormones in Neurodegenerative Diseases.
Vegeto E; Villa A; Della Torre S; Crippa V; Rusmini P; Cristofani R; Galbiati M; Maggi A; Poletti A
Endocr Rev; 2020 Apr; 41(2):273-319. PubMed ID: 31544208
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
Di Matteo V; Esposito E
Curr Drug Targets CNS Neurol Disord; 2003 Apr; 2(2):95-107. PubMed ID: 12769802
[TBL] [Abstract][Full Text] [Related]
7. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
[TBL] [Abstract][Full Text] [Related]
8. Potential of Therapeutic Small Molecules in Apoptosis Regulation in the Treatment of Neurodegenerative Diseases: An Updated Review.
Dailah HG
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364033
[TBL] [Abstract][Full Text] [Related]
9. Physical Exercise-Induced Myokines in Neurodegenerative Diseases.
Lee B; Shin M; Park Y; Won SY; Cho KS
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071457
[TBL] [Abstract][Full Text] [Related]
10. Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment.
Pathak N; Vimal SK; Tandon I; Agrawal L; Hongyi C; Bhattacharyya S
Metab Brain Dis; 2022 Jan; 37(1):67-104. PubMed ID: 34719771
[TBL] [Abstract][Full Text] [Related]
11. Sirtuins and Their Implications in Neurodegenerative Diseases from a Drug Discovery Perspective.
Yeong KY; Berdigaliyev N; Chang Y
ACS Chem Neurosci; 2020 Dec; 11(24):4073-4091. PubMed ID: 33280374
[TBL] [Abstract][Full Text] [Related]
12. From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology.
Toader C; Dobrin N; Brehar FM; Popa C; Covache-Busuioc RA; Glavan LA; Costin HP; Bratu BG; Corlatescu AD; Popa AA; Ciurea AV
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003309
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis.
Dunkel P; Chai CL; Sperlágh B; Huleatt PB; Mátyus P
Expert Opin Investig Drugs; 2012 Sep; 21(9):1267-308. PubMed ID: 22741814
[TBL] [Abstract][Full Text] [Related]
14. Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases.
Sheinerman KS; Toledo JB; Tsivinsky VG; Irwin D; Grossman M; Weintraub D; Hurtig HI; Chen-Plotkin A; Wolk DA; McCluskey LF; Elman LB; Trojanowski JQ; Umansky SR
Alzheimers Res Ther; 2017 Nov; 9(1):89. PubMed ID: 29121998
[TBL] [Abstract][Full Text] [Related]
15. Advances in Applying Computer-Aided Drug Design for Neurodegenerative Diseases.
Salman MM; Al-Obaidi Z; Kitchen P; Loreto A; Bill RM; Wade-Martins R
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925236
[TBL] [Abstract][Full Text] [Related]
16. Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
Peng B; Yang Q; B Joshi R; Liu Y; Akbar M; Song BJ; Zhou S; Wang X
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230811
[TBL] [Abstract][Full Text] [Related]
17. The Microbiome as a Modifier of Neurodegenerative Disease Risk.
Fang P; Kazmi SA; Jameson KG; Hsiao EY
Cell Host Microbe; 2020 Aug; 28(2):201-222. PubMed ID: 32791113
[TBL] [Abstract][Full Text] [Related]
18. The potential use of tetracyclines in neurodegenerative diseases and the role of nano-based drug delivery systems.
Rahmani M; Negro Álvarez SE; Hernández EB
Eur J Pharm Sci; 2022 Aug; 175():106237. PubMed ID: 35710076
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of treatment effects in Alzheimer's and other neurodegenerative diseases by MRI and MRS.
Mueller SG; Schuff N; Weiner MW
NMR Biomed; 2006 Oct; 19(6):655-68. PubMed ID: 16986115
[TBL] [Abstract][Full Text] [Related]
20. The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases.
Maher P
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]